Oklahoma's Integris Health to Join Kaiser-Backed Risant Network

Key points

• Integris Health will become the third system under Risant Health, following Geisinger and Cone Health.
• The transaction is expected to close in Q1 2026, pending regulatory approvals.
• Integris will keep its Oklahoma City headquarters, leadership team, and medical staff.
• Risant Health aims to integrate value-based care models and technology investments.
• The deal follows a period of financial strain for Integris, including a projected $130 million net revenue loss.

Background

Risant Health was established in 2023 by Kaiser Permanente to expand access to value-based care. It previously acquired Geisinger Health in Pennsylvania and Cone Health in North Carolina in 2024. Integris Health, which operates 16 hospitals and employs 13,000 people, recently faced financial challenges due to federal funding cuts, leading to minor staffing reductions and service adjustments. This acquisition represents Risant’s entry into the Midwest market.

How outlets are covering it

News9 and KOCO emphasized the preservation of Integris’s local identity, leadership, and community roots, highlighting assurances from CEO Timothy Pehrson that the mission and operations would remain unchanged. The Oklahoman provided deeper financial context, noting that Integris faces a $130 million net revenue loss due to federal policy changes, though executives stated this was unrelated to the acquisition. All sources agreed that the deal aims to enhance value-based care and technology capabilities, with the Oklahoma State Chamber and Mayor David Holt expressing optimism about the partnership’s potential to improve healthcare access and workforce health in the state.

Why it matters

This acquisition signals a significant shift in Oklahoma’s healthcare landscape, integrating a major regional system into a national value-based care network. It may improve access to advanced clinical tools and reduce wait times, as seen in Risant’s other acquisitions. For Oklahoma, it offers a pathway to enhanced healthcare infrastructure without losing local control, potentially strengthening the state’s competitiveness and workforce health.

What to watch

Regulatory approvals are required before the deal can close, with completion expected in the first quarter of 2027. Integris will begin integrating Risant’s value-based care models, technology, and clinical guidelines. Stakeholders will monitor for any changes in service delivery, wait times, and financial stability as the transition progresses.